Abingworth as of Dec. 31, 2022
Portfolio Holdings for Abingworth
Abingworth holds 19 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 31.5 | $97M | 2.0M | 47.95 | |
| Verona Pharma Sponsored Ads (VRNA) | 20.9 | $64M | 2.5M | 26.13 | |
| Vera Therapeutics Cl A (VERA) | 18.7 | $57M | 3.0M | 19.35 | |
| Hillevax (HLVX) | 10.0 | $31M | 1.8M | 16.73 | |
| Adicet Bio (ACET) | 6.2 | $19M | 2.1M | 8.94 | |
| Phathom Pharmaceuticals (PHAT) | 5.2 | $16M | 1.4M | 11.22 | |
| Reneo Pharmaceuticals (RPHM) | 1.6 | $4.8M | 2.1M | 2.33 | |
| Sientra | 1.1 | $3.4M | 1.7M | 2.03 | |
| Jasper Therapeutics | 0.9 | $2.7M | 5.6M | 0.48 | |
| Soleno Therapeutics (SLNO) | 0.8 | $2.4M | 1.2M | 1.98 | |
| Nucana Sponsored Adr (NCNA) | 0.7 | $2.2M | 3.3M | 0.66 | |
| Effector Therapeutics | 0.7 | $2.1M | 4.8M | 0.43 | |
| Spruce Biosciences (SPRB) | 0.6 | $2.0M | 1.8M | 1.10 | |
| Paratek Pharmaceuticals | 0.6 | $1.9M | 1.0M | 1.87 | |
| Cymabay Therapeutics | 0.3 | $822k | 131k | 6.27 | |
| Exicure Com New (XCUR) | 0.1 | $324k | 282k | 1.15 | |
| Aeglea Biotherapeutics | 0.0 | $108k | 241k | 0.45 | |
| Molecular Templates | 0.0 | $66k | 200k | 0.33 | |
| Obseva Sa | 0.0 | $13k | 88k | 0.14 |
